TRGT
Targacept Inc
Clinical-stage biopharmaceutical company developing neuronal nicotinic receptor (NNR) modulators to treat central nervous system diseases and disorders
CUSIP: 87611R306HealthcareUS1 holder
Total Value
$33.42M
Total Shares
6.00M
Net Share Change
+6.00M
Activity
1 buying
Investor
Value
Shares
Weight
Change
